financetom
Business
financetom
/
Business
/
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Telephone and Data Systems Swings to Q1 Profit, Operating Revenue Falls
May 3, 2024 6:41 AM

09:26 AM EDT, 05/03/2024 (MT Newswires) -- Telephone and Data Systems ( TDS/PV ) reported Q1 earnings Friday of $0.10 per diluted share, swinging from a loss of $0.08 a year earlier.

Two analysts polled by Capital IQ expected a loss of $0.12.

Operating revenue for the quarter ended March 31 was $1.26 billion, down from $1.30 billion a year earlier.

Two analysts surveyed by Capital IQ expected $1.26 billion.

For 2024, the company continues to expect service revenue of $2.95 billion to $3.05 billion from its United States Cellular (USM) unit and operating revenue of $1.07 billion to $1.10 billion from its TDS Telecom unit.

Shares of the company were up 1.5% in recent Friday premarket activity.

Price: 16.45, Change: +0.24, Percent Change: +1.48

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Music streaming firms urge European Commission to reject Apple's proposal in App Store case
Music streaming firms urge European Commission to reject Apple's proposal in App Store case
May 8, 2024
May 8 (Reuters) - A group that represents audio streaming firms including Spotify ( SPOT ) and France's Deezer in Europe has urged the European Commission to reject Apple's ( AAPL ) proposal in a music streaming case. Digital Music Europe expressed concern in a letter submitted to the European Commission on Tuesday that Apple's ( AAPL ) proposal to...
Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine
Cel-Sci Gets US FDA Clearance to Proceed With Confirmatory Study for Cancer Drug Multikine
May 8, 2024
04:02 PM EDT, 05/08/2024 (MT Newswires) -- Cel-Sci ( CVM ) said Wednesday the US Food and Drug Administration indicated in a recent meeting that the company can move forward with a confirmatory registration study of its investigational cancer treatment Multikine. The confirmatory trial needs to enroll 212 subjects and will be conducted in patients with newly diagnosed advanced primary...
Innergex First-Quarter Loss Widens More Than Expected
Innergex First-Quarter Loss Widens More Than Expected
May 8, 2024
04:00 PM EDT, 05/08/2024 (MT Newswires) -- Innergex Renewable Energy ( INGXF ) said Wednesday reported a wider than expected first-quarter loss. The renewable-power company posted a first-quarter loss attributable to owners of C$37.66 million, or C$0.21 per share, in the period, compared to a loss of $12.03 million, or $0.08, a year earlier and wider than the consensus estimate...
Sector Update: Consumer
Sector Update: Consumer
May 8, 2024
03:24 PM EDT, 05/08/2024 (MT Newswires) -- Consumer stocks were retreating late Wednesday afternoon, with the Consumer Staples Select Sector SPDR Fund (XLP) down 0.3% and the Consumer Discretionary Select Sector SPDR Fund (XLY) shedding 0.4%. In corporate news, Shopify ( SHOP ) reported better-than-expected Q1 results amid double-digit gross merchandise volume gains, but it flagged a sales growth slowdown...
Copyright 2023-2026 - www.financetom.com All Rights Reserved